Viewing Study NCT04501757


Ignite Creation Date: 2025-12-24 @ 6:56 PM
Ignite Modification Date: 2025-12-30 @ 7:56 PM
Study NCT ID: NCT04501757
Status: NO_LONGER_AVAILABLE
Last Update Posted: 2022-12-08
First Post: 2020-07-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Naxitamab and GM-CSF in People With Neuroblastoma
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module